U.S. Influenza Vaccines Market to Reflect Significant Incremental Opportunity During 2018-2025
Influenza commonly
referred as flu is a contagious respiratory illness caused by
influenza virus. The virus can cause mild to severe illness,
resulting in serious outcomes such as hospitalization or death.
Geriatric population, pregnant women, and people with chronic health
conditions are at high risk of serious flu complications. Influenza
virus is responsible for seasonal epidemic events and are classified
into two types of influenza virus, including A and B. The influenza
vaccines market is expected to gain significant traction as number of
manufacturers are increasing the production capacity of vaccines for
use in the U.S. market for the 2017–2018 influenza season using the
innovative technologies such as egg-based, cell-based, and
recombinant technologies.
Request Sample
Copy Of This Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1127
Market
Dynamics
The major factors
driving growth of the U.S. influenza vaccines market include rapid
advancements in technology for development of new vaccines such as
recombinant and cell-based technologies, resulting in increasing
production of the vaccines. Influenza flu vaccination have the
potential to reduce the risk of flu-associated hospitalization among
children and adults. According to the Centers for Disease Control and
Prevention, 2015, flu vaccinations prevented an around 1.9 million
flu illnesses, 966,000 flu-associated medical visits, and around
67,000 flu-associated hospitalizations, representing 6.5% lowering of
disease burden in the U.S. Moreover, the collaborative efforts of
various government bodies such as U.S. Department of Health and Human
Services’ Biomedical Advanced Research and Development Authority
(BARDA) with the private sector has led to development of improved
influenza vaccine technologies in the U.S. This in turn, has improved
influenza pandemic preparedness in the country.
Key features
of the study:
-
This report provides in-depth analysis of U.S. influenza vaccines market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
-
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
-
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
-
It profiles leading players in the U.S. influenza vaccines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
-
Key companies covered as a part of this study include Sanofi Pasteur, Seqirus Vaccines Ltd., GlaxoSmithKline Plc., and Medimmune
Detailed
Segmentation:
-
U.S. Influenza Vaccines Market, By Vaccine Type:
-
Trivalent Vaccines
-
Quadrivalent Vaccines
-
-
U.S. Influenza Vaccines Market, By Virus Type:
-
Influenza Virus Type A
-
Influenza Virus Type B
-
-
U.S. Influenza Vaccines Market, By Age Group:
-
Pediatrics
-
Adults
-
-
Company Profiles
Government
initiatives to tackle such events is a major factor propelling growth
of the U.S. influenza vaccine market
The government
agencies in the U.S. are focusing on collaborations in order to
increase the supply of influenza vaccines. For instance, the Centers
for Disease Control and Prevention (CDC), the Food and Drug
Administration (FDA), and the National Institutes of Health (NIH)
have partnered with the U.S. Department of Health and Human Services
Biomedical Advanced Research and Development Authority (BARDA) to
support the advanced development of new and better influenza
vaccines, as a part of inter-agency government effort in the U.S.
Click To Read More On U.S.
Influenza Vaccines Market
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment